Nov 04, 2024
2:1
For every share held, investors received 2. The price per share adjusted from $0.30 to $0.15.
The split itself did not change the total investment value.
Regen BioPharma, Inc. (RGBP) trades on the Other OTC in the Biotechnology industry.
Regen BioPharma, Inc. company overviewThe latest split shown was on November 4, 2024. It was a 2-for-1 forward split, so shareholders received 2 shares for every share they held.
This history records 2 splits between March 6, 2023 and November 4, 2024.